Patient Square Capital Agreed To Acquire Eargo For $2.55 Per Share In Cash - 8K
Portfolio Pulse from Benzinga Newsdesk
Private equity firm Patient Square Capital has agreed to acquire hearing aid manufacturer Eargo for $2.55 per share in cash, according to an 8K filing.
October 30, 2023 | 11:48 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Eargo's stock is likely to be impacted by the acquisition news. The agreed price of $2.55 per share in cash may influence the stock's short-term price.
Acquisition news typically impacts the stock price of the company being acquired. In this case, Eargo's stock (EAR) is likely to be influenced by the agreed acquisition price of $2.55 per share in cash. Investors may adjust their positions based on this news, leading to potential fluctuations in the stock's short-term price.
CONFIDENCE 90
IMPORTANCE 100
RELEVANCE 100